Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients

Publisher Website
Google Scholar
Abstract
Although it is widely believed that cytotoxic T lymphocytes (CTL) are responsible for severe flares of chronic hepatitis B that lead to liver failure, the published evidence to support this hypothesis is weak. The frequency of the I27V mutation in the HBV core gene, which produces a core 18–27 peptide capable of binding HLA‐A*02, was compared in Chinese patients with severe liver inflammation (n = 77, including 39 with acute‐on‐chronic liver failure), moderate liver inflammation (n = 44) and inactive disease (n = 45). The frequency with which V27 reverted to the wild‐type I27 was compared in severe liver inflammation patients who were either HLA‐A*02 positive (n = 5) or negative (n = 5). The frequency of patients with a V27 positive HBV was higher in severe than in moderate liver inflammation (23.4% vs. 6.8%, P = 0.02) or inactive disease (23.4% vs. 4.7%, P = 0.006). After a minimum of 3 months follow‐up, the frequency of reversion of V27 to the wild‐type I27 was higher in HLA‐A*02 positive than negative patients (5/5 vs. 1/5, P = 0.05). In summary, this is the first data showing an association between a specific amino acid mutation (I27V) and severe liver inflammation in patients with chronic hepatitis B. This mutation would produce a peptide that is known to bind HLA‐A*02 and stimulate CTL. The high frequency of reversion to wild‐type I27 in HLA‐A*02 positive subjects suggests that CTL recognizing this peptide exist, and is consistent with the possibility that they contribute to the pathophysiology of severe liver inflammation in chronic hepatitis B. J. Med. Virol. 83:218–224, 2011.